Nearly 2,000 drug plants are overdue for FDA checks after COVID delays, AP finds

U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected during disruptions caused by COVID-19

Sep 5, 2024 - 16:00
Nearly 2,000 drug plants are overdue for FDA checks after COVID delays, AP finds
U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected during disruptions caused by COVID-19

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow